TD Cowen Reiterates Buy Rating on Incyte (INCY) Post Mixed Trial Data
Tweet Send to a Friend
TD Cowen analyst Marc Frahm reiterated a Buy rating and $88.00 price target on Incyte (NASDAQ: INCY).The analyst commented: "At ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
